Day: October 17, 2025
The 10 Scariest Stephen King Adaptations, Ranked
Ahead of ‘It: Welcome to Derry’ arriving on HBO, we’re counting down our favorite Stephen King nightmares from screens big and small.
DRW’s Wilson Slams Exchanges Over Practices During Crypto Crash
Donald R. Wilson, founder of Chicago-based proprietary trading powerhouse DRW Holdings LLC, criticized the practices of digital asset exchanges during last week’s crypto market meltdown, where cascading liquidations led to record losses.
Stream It Or Skip It: ‘Boston Blue’ On CBS, A Contrived ‘Blue Bloods’ Spinoff That Finds Donnie Wahlberg’s Danny Reagan In The Boston PD
The spinoff also stars Sonequa Martin-Green, Gloria Reuben, Maggie Lawson, Marcus Scribner and Ernie Hudson.
Fortress Power Launches the eBoost Energy Storage System
16kWh Battery System Offers Simplified Design, Sustainable Backup Power, and Seamless Integration with the Envy Duo 21 Inverter LANGHORNE, Pa., Oct. 17, 2025 /PRNewswire-PRWeb Fortress Power, a leading provider of advanced battery energy storage solutions, proudly announces the.
Switch 2 vs Switch 1 Sales Comparison – August 2025
The VGChartz sales comparison series of articles are updated monthly and each one focuses on a different sales comparison using our estimated video game hardware figures. The charts include comparisons between the PlayStation 5, Xbox Series X|S, and Nintendo Switch, as well as with older platforms. There are articles based on our worldwide estimates, as well as the US, Europe, and Japan. This monthly series compares the aligned worldwide sales of the Nintendo Switch 2 and Nintendo Switch 1. The Nintendo Switch 2 launched in June 2025 and the Nintendo Switch launched in March 2017. This does mean the holiday periods for the two consoles do not lineup. Switch 2 Vs. Switch 1 Worldwide: Gap change in latest month: 618, 870 Switch 2 Total Lead: 4, 581, 656 Switch 2 Switch 2 Total Sales: 8, 160, 186 Switch 1 Total Sales: 3, 578, 530 August 2025 is the 3rd month the Nintendo Switch 2 has been available for. During the latest month, the Switch 2 has outsold the Switch 1 by 0. 62 million units when you align the launches. The Switch 2 is now ahead of the Switch 1 by 4. 58 million units. The 3rd month for the Switch 2 is August 2025, while for the Switch 1 it is May 2017. The Switch 2 has sold 8. 16 million units, while the Switch 1 sold 3. 58 million units during the same timeframe. The Nintendo Switch 1 has sold 151. 62 million units to date. The Switch 2 is currently 143. 46 million units behind the lifetime sales of the Switch 1. A life-long and avid gamer, William D’Angelo was first introduced to VGChartz in 2007. After years of supporting the site, he was brought on in 2010 as a junior analyst, working his way up to lead analyst in 2012 and taking over the hardware estimates in 2017. He has expanded his involvement in the gaming community by producing content on his own YouTube channel and Twitch channel. You can follow the author on Bluesky. Full Article.
Police investigating after man shot on SEPTA platform in Center City
An investigation is underway after officials said a man was shot on a SEPTA platform in Center City, Philadelphia, early Friday morning.
DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, Oct. 17, 2025 (GLOBE NEWSWIRE) — — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected].
Cytokinetics, Incorporated (NASDAQ:CYTK)Class Period: December 27, 2023 – May 6, 2025Lead Plaintiff Deadline: November 17, 2025
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Defendants had knowingly or recklessly omitted a REMS from the initial NDA submission, despite prior FDA discussions about safety and risk mitigation; (2) the subsequent REMS submission necessitated a three-month delay in the FDA's process for potential approval; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you are a Cytokinetics shareholder who suffered a loss, click here to participate.
Quanex Building Products Corporation (NYSE:NX)Class Period: December 12, 2024 – September 5, 2025Lead Plaintiff Deadline: November 18, 2025
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material …Full story available on Benzinga.com
Opinion: Scout leaves his mark on College Preparatory Middle School
Little did I know when I joined Scouts at six years old that it would shape my life beyond friendships and high-adventure treks.
